CERS vs ZTS · rev $111.1M vs P/E 25, rev $2.47B
Cerus Corporation (CERS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CERS revenue for 2026-06-30 was $111.1M. Net income was -$4.6M. CERS currently screens at market cap $294.4M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
CERS currently screens at market cap $294.4M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the CERS and ZTS stock pages for the full models.
Not investment advice.